4.6 Article

A novel clinician-delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2)

Related references

Note: Only part of the references are listed.
Article Oncology

Evaluation of the validity and screening performance of a revised single-item fear of cancer recurrence screening measure (FCR-1r)

Allan 'Ben' Smith et al.

Summary: This study examined the validity of a revised measure for fear of cancer recurrence (FCR) and its screening performance. The revised measure (FCR-1r) showed concurrent and convergent validity and accurately screened for FCR. Further evaluation is needed to compare the screening performance of FCR-1r with the anxiety item on ESAS-r in routine care.

PSYCHO-ONCOLOGY (2023)

Review Oncology

What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis

Yvonne L. Luigjes-Huizer et al.

Summary: Objective Care for fear of cancer recurrence (FCR) is the most common unmet need among cancer survivors. This study provides a comprehensive overview of the prevalence and severity of FCR among cancer survivors and patients, and reveals the associations between FCR and clinical and demographic characteristics. The findings emphasize the importance of addressing FCR and providing treatment to those in need.

PSYCHO-ONCOLOGY (2022)

Review Oncology

A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness

Jake Thomas Warton Williams et al.

Summary: Fear of cancer recurrence (FCR) is a common and burdensome psychological condition affecting cancer survivors. This systematic review synthesised evidence on FCR-related healthcare usage, costs, and the cost-effectiveness of FCR treatments. The reviewed studies suggest that FCR is associated with increased healthcare usage and certain treatments may be cost-effective in reducing FCR and improving quality of life. Further high-quality research is needed to confirm these findings and ensure the implementation of efficient FCR treatments in the future.

PSYCHO-ONCOLOGY (2021)

Review Medicine, General & Internal

A price tag on clinical empathy? Factors influencing its cost-effectiveness

J. Howick et al.

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2020)

Article Public, Environmental & Occupational Health

The Elusive Search for Success: Defining and Measuring Implementation Outcomes in a Real-World Hospital Trial

Heather L. Shepherd et al.

FRONTIERS IN PUBLIC HEALTH (2019)